Rituximab: Enhancing outcome of autologous stem cell transplantation in non-Hodgkin's lymphoma

This publication has 14 references indexed in Scilit:

• Rituximab and CHOP Induction Therapy for Newly Diagnosed Mantle-Cell Lymphoma: Molecular Complete Responses Are Not Predictive of Progression-Free Survival
  Journal of Clinical Oncology, 2002
• Autologous stem cell transplantation in follicular non-Hodgkin's lymphoma
  Bone Marrow Transplantation, 2002
• Survival Benefit of High-Dose Therapy in Poor-Risk Aggressive Non-Hodgkin’s Lymphoma: Final Analysis of the Prospective LNH87–2 Protocol—A Groupe d’Etude des Lymphomes de l’Adulte Study
  Journal of Clinical Oncology, 2000
• Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion
  Blood, 2000
• In vivodepletion of B cells using a combination of high-dose cytosine arabinoside/mitoxantrone and rituximab for autografting in patients with non-Hodgkin's lymphoma
  British Journal of Haematology, 2000
• The CUP trial: A randomized study analyzing the efficacy of high dose therapy and purging in low-grade non-Hodgkin's lymphoma (NHL)
  Annals of Oncology, 2000
• The effect of Rituximab on patients with follicular and mantle-cell lymphoma
  Annals of Oncology, 2000
• European Phase II Study of Rituximab (Chimeric Anti-CD20 Monoclonal Antibody) for Patients With Newly Diagnosed Mantle-Cell Lymphoma and Previously Treated Mantle-Cell Lymphoma, Immunocytoma, and Small B-Cell Lymphocytic Lymphoma
  Journal of Clinical Oncology, 2000
• Long-Term Follow-Up of Autologous Bone Marrow Transplantation in Patients With Relapsed Follicular Lymphoma
  Blood, 1999
• Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma
  New England Journal of Medicine, 1995